GlassScriptPhysician profile
Terry Brock
NPI 1851991954
$2,142.72
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $68.82 · 2022: $668 · 2023: $1,268 · 2024: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,405.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $366.65 | 2022-2023 | Apretude, Dovato |
| Abbvie INC. | $347.00 | 2022-2024 | |
| Gilead Sciences, INC. | $244.04 | 2022-2024 | |
| Novo Nordisk INC | $235.79 | 2023-2024 | Rybelsus, Ozempic |
| Bausch Health US, LLC | $172.45 | 2021-2023 | Aplenzin |
| Bayer Healthcare Pharmaceuticals INC. | $128.28 | 2023 | |
| Janssen Biotech, INC. | $124.23 | 2023 | Symtuza |
| Amarin Pharma, INC. | $121.19 | 2021-2022 | |
| Glaxosmithkline, LLC. | $99.30 | 2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.82 | 2022-2024 | Xifaxan |
| Theratechnologies INC. | $56.39 | 2022 | |
| Merck Sharp & Dohme LLC | $47.66 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $46.91 | 2022-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.75 | 2021-2022 | |
| Tolmar, INC. | $14.39 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $14.05 | 2023 | Nuzyra |
| Pfizer INC. | $13.90 | 2023 | |
| Virtus Pharmaceuticals LLC | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Brock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.